filings.toolsItem 2. Properties.
4K characters. Original on sec.gov · Markdown
Item 2. Properties.
The following is a summary of Cooper's principal facilities as of October 31, 2023. We generally lease our office and operations facilities but own several manufacturing and research and development facilities, including 303,872 square feet in the United Kingdom, 347,329 square feet in Costa Rica, 115,000 square feet in Puerto Rico, 493,833 square feet in New York, 80,000 square feet in Arizona and 34,453 square feet in Texas. The following table lists those properties that we lease. Our lease agreements expire at various dates through the year 2045. We believe our properties are suitable and adequate for our businesses.
| Location | Approximate Leased Square Feet | Operations | |||||||||
| AMERICAS | |||||||||||
| United States: | |||||||||||
| California | 200,140 | Executive offices; CooperVision manufacturing, research & development and administrative offices; CooperSurgical research & development, distribution and administrative offices | |||||||||
| New York | 132,813 | CooperVision and CooperSurgical distribution and administrative offices | |||||||||
| New Jersey | 37,700 | CooperSurgical research and development, distribution and administrative offices | |||||||||
| Connecticut | 275,337 | CooperSurgical distribution and administrative offices | |||||||||
| Arizona | 45,000 | CooperVision manufacturing and distribution | |||||||||
| Puerto Rico | 740,954 | CooperVision manufacturing, research and development and distribution | |||||||||
| Canada | 63,836 | CooperVision manufacturing and administrative office; CooperSurgical research & development, distribution and administrative offices | |||||||||
| Brazil | 22,048 | CooperVision distribution and administrative office | |||||||||
| Other Americas | 58,365 | CooperVision distribution and administrative offices; CooperSurgical research & development, distribution and administrative offices | |||||||||
| EMEA | |||||||||||
| United Kingdom | 667,384 | CooperVision manufacturing, distribution, research & development and administrative offices; CooperSurgical research & development, administrative offices | |||||||||
| Hungary | 330,245 | CooperVision manufacturing | |||||||||
| Belgium | 282,108 | CooperVision distribution | |||||||||
| Spain | 181,145 | CooperVision distribution and administrative office; CooperSurgical administrative office | |||||||||
| Netherlands | 279,288 | CooperVision administrative offices; CooperSurgical research & development and distribution | |||||||||
| Other EMEA | 148,980 | CooperVision distribution and administrative offices; CooperSurgical administrative offices | |||||||||
| ASIA PACIFIC | |||||||||||
| Japan | 109,163 | CooperVision distribution and administrative offices; CooperSurgical laboratory/research & development | |||||||||
| Australia | 40,139 | CooperVision marketing and distribution; CooperSurgical research & development and distribution | |||||||||
| Other Asia Pacific | 92,517 | CooperVision distribution, marketing and administrative offices; CooperSurgical marketing and administrative office |
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Previous: Item 1B. Unresolved Staff Comments. · Next: Item 3. Legal Proceedings.